Neuroscience

Top 40 High School Scientists in Prestigious Regeneron Science Talent Search to Compete for $1.8 Million in Awards

Retrieved on: 
Wednesday, January 24, 2024

TARRYTOWN, N.Y. and WASHINGTON, Jan. 24, 2024 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in this year's Regeneron Science Talent Search, the nation's oldest and most prestigious science and math competition for high school seniors.

Key Points: 
  • Regeneron Science Talent Search Showcases Exceptional Young Leaders with Innovative Ideas in Science, Technology, Engineering and Math (STEM)
    TARRYTOWN, N.Y. and WASHINGTON, Jan. 24, 2024 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in this year's Regeneron Science Talent Search , the nation's oldest and most prestigious science and math competition for high school seniors.
  • "We applaud this dynamic group of Regeneron Science Talent Search finalists on their impressive achievement," said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.
  • The top 10 Regeneron Science Talent Search 2024 winners will be announced during an awards ceremony on March 12, streamed live from Washington D.C.
  • In total, more than $3 million in awards will be distributed throughout the Regeneron Science Talent Search.

Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson's Disease

Retrieved on: 
Tuesday, January 23, 2024

The new research framework stands to accelerate and increase the success of scientific discovery and therapeutic development at all stages of Parkinson's.

Key Points: 
  • The new research framework stands to accelerate and increase the success of scientific discovery and therapeutic development at all stages of Parkinson's.
  • And ultimately, a treatment that targets the biology of the disease — rather than just its symptoms — is the way to reach a cure.
  • (A similar biological framework in Alzheimer's disease resulted in successful trials and new drug approvals, with the first drugs to slow Alzheimer's-related cognitive decline appearing in 2022 and 2023.)
  • This landmark step forward was made possible by the breakthrough discovery of a test — validated in April 2023 by The Michael J.

Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson's Disease

Retrieved on: 
Tuesday, January 23, 2024

The new research framework stands to accelerate and increase the success of scientific discovery and therapeutic development at all stages of Parkinson's.

Key Points: 
  • The new research framework stands to accelerate and increase the success of scientific discovery and therapeutic development at all stages of Parkinson's.
  • And ultimately, a treatment that targets the biology of the disease — rather than just its symptoms — is the way to reach a cure.
  • (A similar biological framework in Alzheimer's disease resulted in successful trials and new drug approvals, with the first drugs to slow Alzheimer's-related cognitive decline appearing in 2022 and 2023.)
  • This landmark step forward was made possible by the breakthrough discovery of a test — validated in April 2023 by The Michael J.

Medical Students Discover Antidote for Anxiety, Stress

Retrieved on: 
Friday, January 19, 2024

MAYWOOD, Ill., Jan. 19, 2024 /PRNewswire/ -- America's youngest doctors and medical students are overwhelmed with anxiety, stress, and burnout: 300 to 400 physicians a year in the US take their own life.

Key Points: 
  • MAYWOOD, Ill., Jan. 19, 2024 /PRNewswire/ -- America's youngest doctors and medical students are overwhelmed with anxiety, stress, and burnout: 300 to 400 physicians a year in the US take their own life.
  • 9.4% of fourth-year medical students and residents reported suicidal thoughts in the prior 2 weeks.
  • A self-care strategy described as effective by medical students is documented in a newly published study.
  • The current study reports Loyola Stritch medical students' outcomes in their own words:
    1.

AHN Allegheny General Hospital Achieves Prestigious Magnet® Designation for Nursing Excellence

Retrieved on: 
Friday, January 19, 2024

PITTSBURGH, Jan. 19, 2024 /PRNewswire-PRWeb/ -- Allegheny General Hospital (AGH), part of the Allegheny Health Network (AHN), has achieved Magnet® designation, a prestigious recognition that reflects the hospital's superior levels of nursing professionalism, teamwork, and patient care.

Key Points: 
  • Allegheny General Hospital (AGH), part of the Allegheny Health Network (AHN), has achieved Magnet® designation, a prestigious recognition that reflects the hospital's superior levels of nursing professionalism, teamwork, and patient care.
  • PITTSBURGH, Jan. 19, 2024 /PRNewswire-PRWeb/ -- Allegheny General Hospital (AGH), part of the Allegheny Health Network (AHN), has achieved Magnet® designation, a prestigious recognition that reflects the hospital's superior levels of nursing professionalism, teamwork, and patient care.
  • This Magnet designation is a reflection of the tireless dedication and exceptional nursing skills of our team at Allegheny General Hospital.
  • It is now the fourth AHN hospital to receive the Magnet designation, part of the network's ongoing campaign to transform the practice of nursing and sustain a culture of nursing excellence and innovation.

The Inner Circle Acknowledges, Ann Papayoti as a Pinnacle Lifetime Member

Retrieved on: 
Tuesday, January 16, 2024

GRAPEVINE, Texas, Jan. 16, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Ann Papayoti is acknowledged as a Pinnacle Lifetime Member for her contributions as a Leading Coach, Author, and Speaker.

Key Points: 
  • GRAPEVINE, Texas, Jan. 16, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Ann Papayoti is acknowledged as a Pinnacle Lifetime Member for her contributions as a Leading Coach, Author, and Speaker.
  • Additionally, she works with small business owners, corporate executives, and their teams to develop leadership skills and create their desired culture.
  • Prior to her coaching career, Ann spent 17 years in the corporate world working for a major airline.
  • With her unwavering commitment to empowering individuals and fostering personal growth, Ann Papayoti is set to make a significant impact with SkyView Coaching, enriching the lives of clients globally.

tapouts Replaces Scrolling for Parenting Tips with Fun Mental Wellbeing Coaching for Kiddos

Retrieved on: 
Tuesday, January 16, 2024

LOS ANGELES, Jan. 16, 2024 /PRNewswire/ -- For many parents, social media has become a place of undue stress and information overload when it comes to advice on how to raise their children. In fact, a study conducted at Pepperdine University linked the use of social media parenting groups with higher cortisol levels, a marker of increased stress.

Key Points: 
  • "Parents often enlist coaches for their kids' sports or new skills, recognizing the value of expert guidance alongside their own support.
  • tapouts is a science-backed program that was developed by educators and scientists to create a fun and safe space that enables children to learn lessons that last a lifetime.
  • It'll give you an idea of whether or not tapouts is the best fit for your child at the moment!
  • For media inquiries, interviews, or more information about tapouts, please contact the Max Borges Agency at [email protected]

Tackling the Poor Sleep Pandemic: FRENZ Brainband by Earable Neuroscience Announces Global Sales After CES 2024 Innovation Award Win

Retrieved on: 
Sunday, January 14, 2024

BOULDER, Colo., Jan. 14, 2024 /PRNewswire/ -- Following its CES Innovation Award for Aging Technology, Earable® Neuroscience announced the global sales of FRENZ™ Brainband, a groundbreaking AI-powered sleep tech wearable designed to help people sleep better. FRENZ Brainband, paired with the complimentary FRENZ AI Sleep Science app, has been clinically proven to help people fall asleep 24 minutes faster on average, as published on Nature Scientific Report. FRENZ is now ready for shipping globally from frenzband.com. The product is currently trending in the Fitness & Activity Monitors category on Amazon.

Key Points: 
  • BOULDER, Colo., Jan. 14, 2024 /PRNewswire/ -- Following its CES Innovation Award for Aging Technology, Earable® Neuroscience announced the global sales of FRENZ™ Brainband, a groundbreaking AI-powered sleep tech wearable designed to help people sleep better.
  • FRENZ Brainband, paired with the complimentary FRENZ AI Sleep Science app, has been clinically proven to help people fall asleep 24 minutes faster on average, as published on Nature Scientific Report .
  • FRENZ Brainband represents a significant advancement in sleep technology, offering precise tracking and real-time brain activity stimulation using non-invasive audio therapy.
  • "FRENZ is a comprehensive, comfortable, all-in-one sleep wearable that provides real-time, direct stimulation with precise data to effectively address sleep issues.

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Retrieved on: 
Wednesday, January 10, 2024

In addition to joining Absci’s Board, Sir Pangalos will co-chair Absci’s Scientific Advisory Board.

Key Points: 
  • In addition to joining Absci’s Board, Sir Pangalos will co-chair Absci’s Scientific Advisory Board.
  • VANCOUVER, Wash., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a generative AI drug creation company, today announced the appointment of seasoned R&D executive Professor Sir Menelas “Mene” Pangalos to its Board of Directors and as co-chair of Absci’s Scientific Advisory Board.
  • Sir Pangalos was the Executive Vice President of BioPharmaceuticals R&D at AstraZeneca.
  • In his dual role, Sir Pangalos will also co-chair Absci’s Scientific Advisory Board.

Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson’s Technologies

Retrieved on: 
Thursday, January 11, 2024

Rune Labs , a precision neurology software and data company, today announced a strategic round of $12 million, increasing the total amount raised by the company to over $42 million.

Key Points: 
  • Rune Labs , a precision neurology software and data company, today announced a strategic round of $12 million, increasing the total amount raised by the company to over $42 million.
  • Jordi Parramon, PhD, CEO, General Partner and Co-Founder of Nexus NeuroTech Ventures and former President of Medical Devices at Verily, will join Rune Labs’ board of directors.
  • “Focused on investing in technologies that can transform how we treat brain disorders, our aim at Nexus NeuroTech Ventures is to support innovative companies like Rune Labs.
  • I strongly believe that Rune Labs and their tool, StrivePD, are set to transform how we receive care and improve outcomes for many people living with Parkinson’s,” said Benjamin Stecher, Chair of the Patient Advisory Board at Rune Labs.